Absence of interaction between erythromycin and a single dose of clozapine

European Journal of Clinical Pharmacology

Volumn 55, Issue 3, 1999, Pages 221-226

  Hagg S ^a   Spigset, O ^a,b   Mjorndal T ^a   Granberg, K ^a   Persbo Lundqvist, G ^a   Dahlqvist, R ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Clozapine; CYP3A4; Drug interaction; Erythromycin; Pharmacokinetics

Indexed keywords

CLOZAPINE; CLOZAPINE DERIVATIVE; ERYTHROMYCIN; NEUROLEPTIC AGENT; NORCLOZAPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DROWSINESS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG HALF LIFE; DRUG METABOLISM; DRUG MIXTURE; DRUG POTENTIATION; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INFECTION; MALE; MYALGIA; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTLESS LEGS SYNDROME; SCHIZOPHRENIA; SPEECH DISORDER; VERTIGO; XEROSTOMIA;

ADULT; ANTI-BACTERIAL AGENTS; ANTIPSYCHOTIC AGENTS; AREA UNDER CURVE; CLOZAPINE; CROSS-OVER STUDIES; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; ERYTHROMYCIN; HUMANS; MALE; MIXED FUNCTION OXYGENASES;

EID: 0033047932     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050621     Document Type: Article

References (30)

1. 1. Bertilsson L, Carrillo JA, Dahl ML et al (1994) Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test. Br J Clin Pharmacol 38: 471-473
2. 2. Jerling M, Lindström L, Bondesson U, Bertilsson L (1994) Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service. Ther Drug Monit 16: 368-374
3. 3. Dahl ML, Llerena A, Bondesson U, Lindström L, Bertilsson L (1994) Disposition of clozapine in man, lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphisms. Br J Clin Pharmacol 37: 71-74
4. 4. Eiermann B, Engel G, Johansson I, Zanger UM, Bertilsson L (1997) The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine. Br J Clin Pharmacol 44: 439-446
5. 5. Linnet K, Olesen OV (1997) Metabolism of clozapine by cDNA-expressed human cytochrome P450 enzymes. Drug Metab Dispos 25: 1379-1382
6. 6. Funderburg LG, Vertrees JE, True JE, Miller AL (1994) Seizure following addition of erythromycin to clozapine treatment. Am J Psychiatry 151: 1840-1841
7. 7. Cohen LG, Chesley S, Eugenio L, Flood JG, Fisch J, Goff DC (1996) Erythromycin-induced clozapine toxic reaction. Arch Intern Med 156: 675-677
8. 8. Ludden TM (1985) Pharmacokinetic interactions of the macrolide antibiotics. Clin Pharmacokinet 10: 63-79
9. 9. von Rosenstiel NA, Adam D (1995) Macrolide antibacterials. Drug interactions of clinical significance. Drug Saf 13: 105-22
10. 10. Spina E, Pisani F, Perucca E (1996) Clinically significant pharmacokinetic drug interactions with carbamazepine. An update. Clin Pharmacokinet 31: 198-214
11. 11. Wietholtz H, Zysset T, Kreiten K, Kohl D, Büchsel R, Matern S (1989) Effect of phenytoin, carbamazepine, and valproic acid on caffeine metabolism. Eur J Clin Pharmacol 36: 401-406
12. 12. Raitasuo V, Lehtovaara R, Huttunen MO (1993) Carbamazepine and plasma levels of clozapine. Am J Psychiatry 150: 169
13. 13. Spigset O, Granberg K, Hägg S, Norström Å, Dahlqvist R (1997) Relationship between fluvoxamine pharmacokinetics and CYP2D6/CYP2C19 phenotype polymorphisms. Eur J Clin Pharmacol 52: 129-133
14. 14. Weigmann H, Hiemke C (1992) Determination of clozapine and its major metabolites in human serum using automated solid-phase extraction and subsequent isocratic high-performance liquid chromatography with ultraviolet detection. J Chromatogr 583: 209-216
15. 15. Klassen M, Edberg SC (1996) Measurement of antibiotics in human body fluids; techniques and significance. In: Lorian V (ed) Antibiotics in laboratory medicine. Williams and Wilkins, Baltimore, pp 230-295
16. 16. Gahramani P, Ellis SW, Lennard LE, Ramsay LE, Tucker GT (1997) Cythochromes P450 mediating the demethylation of amitryptyline. Br J Clin Pharmacol 43: 137-144
17. 17. Raaska K, Neuvonen PJ (1998) Serum concentrations of clozapine and N-desmethyl-clozapine are unaffected by the potent CYP3A4 inhibitor itraconazole. Eur J Clin Pharmacol 54: 167-170
18. 18. Matthay RA, Matthay MA, Weinberger MM (1976) Grand mal seizure induced by oral theophylline. Thorax 31: 470-471
19. 19. Chang KC, Bell TD, Lauer BA, Chai H (1978) Altered theophylline pharmacokinetics during acute respiratory viral illness. Lancet 27 (1): 1132-1133
20. 20. Kraemer MJ, Furukawa CT, Koup R, Shapiro GG, Pierson WE Bierman CW (1982) Altered theophylline clearance during an influenza B outbreak. Pediatrics 69: 476-480
21. 21. Renton KW, Gray JD, Hall RI (1980) Decreased elimination of theophylline after influenza vaccination. Can Med Assoc J 123: 288-290
22. 22. Shedlofsky SI, Israel BC, McClain CJ, Hill DB, Blouin RA (1994) Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism. J Clin Invest 94: 2209-2214
23. 23. Periti P, Mazzei T, Mini E, Novelli A (1992) Pharmacokinetic drug interactions of macrolides. Clin Pharmacokinet 23: 106-131
24. 24. Kucers A, Crowe SM, Grayson ML, Hoy JF (1997) The use of antibiotics. Fifth edition, Butterworth Heinemann, Oxford 606-628
25. 25. Janssens J, Peeters TL, Vantrappen G et al (1990) Improvement of gastric emptying in diabetic gastroparesis by erythromycin. New Engl J Med 322: 1028-1031
26. 26. Laudry C, Vidon N, Sogni P et al (1995) Effects of erythromycin on gastric emptying, duodeno-caecal transit time, gastric and biliopancreatic secretion during continuous gastric infusion of a liquid diet in healthy volunteers. Eur J Gastroenterol Hepatol 7: 797-802
27. 27. Hägg S, Spigset O, Edwardsson H, Björk H (1999) Prolonged sedation and slowly decreasing clozapine serum concentrations after an overdose. J Clin Psychopharmacol 19
28. 28. Byerly MJ, DeVane CL (1996) Pharmacokinetics of clozapine and risperidone: a review of recent literature. J Clin Psychopharmacol 16: 177-187
29. 29. Jann MW, Grimsley SR, Gray EC, Chang WH (1993) Pharmacokinetics and pharmacodynamics of clozapine. Clin Pharmacokinet 24: 161-176
30. 30. Choc MG, Lehr RG, Hsuan F et al (1987) Multiple-dose pharmacokinetics of clozapine in patients. Pharm Res 4: 402-405